People · Operator

CYNTHIA M. COLLINS, MBA

Named in public records as an officer, director or promoter · active 2021–2021 · Biotechnology

1
Companies
2
Filings
$59.7M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Triumvira Immunologics Inc.BiotechnologySeries C$59.7M$1.8B2021
Operator network

CYNTHIA M. COLLINS, MBA at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

SCOTT C. SMITH · 3 companies · 1 sharedSCOTT C. SMITHBRIAN M. BLOOM · 2 companies · 1 sharedBRIAN M. BLOOMCYNTHIA C. COLLINS, MBA · 1 companies · 1 sharedCYNTHIA C. COLLIN…DANIEL C. JANSE · 1 companies · 1 sharedDANIEL C. JANSEELIZABETH C. WILLIAMS · 1 companies · 1 sharedELIZABETH C. WILL…JON C. IRVIN · 1 companies · 1 sharedJON C. IRVINJURGEN M. ECKHARDT · 1 companies · 1 sharedJURGEN M. ECKHARDTLEE M. COOPER · 1 companies · 1 sharedLEE M. COOPERPAUL LAMMERS, MD, MSc · 1 companies · 1 sharedPAUL LAMMERS, MD,…SCOTT M. SMITH · 1 companies · 1 sharedSCOTT M. SMITHSHAAN C. GANDHI, MD, DPhil · 1 companies · 1 sharedSHAAN C. GANDHI, …TERESA C. MCROBERTS · 1 companies · 1 sharedTERESA C. MCROBER…WIDYA M. MULYASASMITA · 1 companies · 1 sharedWIDYA M. MULYASAS…Triumvira Immunologics Inc. · $59.7M raisedTriumvira Immunologic…CYNTHIA M. COLLINS, MBACM
CYNTHIA M. COLLINS, MBA Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside CYNTHIA M. COLLINS, MBA on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
SCOTT C. SMITH13
BRIAN M. BLOOM12
JURGEN M. ECKHARDT11
TERESA C. MCROBERTS11
PAUL LAMMERS, MD, MSc11
ELIZABETH C. WILLIAMS11
JON C. IRVIN11
WIDYA M. MULYASASMITA11
LEE M. COOPER11
SHAAN C. GANDHI, MD, DPhil11
SCOTT M. SMITH11
CYNTHIA C. COLLINS, MBA11
DANIEL C. JANSE11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.